DoctorMatthew Sharman

Senior Lecturer in Health Science & Health Promotion

Health Sciences

  • Senior Lecturer in Health Science & Health Promotion
    Health Sciences
  • +61 3 6324 5417 (Work)
  • UTAS Health, School of Health Sciences, PO Box 4094, Invermay, Tasmania, 7248, Australia

RESEARCH SUMMARy

Dr Sharman’s research aligns with the University’s research theme of Better Health. His current research interests focus on understanding the role that lifestyle factors, particularly nutrition and physical activity, play in the prevention of chronic disease. His work is driven by the potential for evidence-based lifestyle approaches to prevent or delay disease onset, reduce disease burden, and improve quality of life across the lifespan.

 

A key focus of Dr Sharman’s current research is diet quality and dietary patterns among regional and rural Australians, with particular interest in how social, geographic and environmental factors influence access to healthy food and nutrition-related health outcomes. He also contributes to research aimed at improving bowel cancer awareness and screening participation in rural and remote communities through community-informed and co-designed health education strategies.

 

More broadly, Dr Sharman’s research spans nutrition science, exercise physiology, cardiovascular and metabolic health, healthy ageing, dementia and Alzheimer’s disease prevention. Across these areas, his work seeks to translate research evidence into practical strategies that support healthier communities, with a particular emphasis on improving health outcomes for people living in regional and rural settings.

FUNDED PROJECTS

  • GRANT
    Co-design of an educational intervention to improve bowel cancer awareness and screening in a rural community
    1 Jan 2022 - 30 Jun 2023
    People funded by this grant:
    • Obamiro K,
    • Lee S,
    • Sharman M,
    • Hoang H,
    • Gadd N
    Project Total: $25,000; Disease awareness within a community is known to help improve uptake of preventative measures. A previous study has suggested a deficiency in bowel cancer awareness in many Tasmania communities. The development of a community-based co-designed educational intervention will lead to improvement in bowel cancer awareness and uptake of bowel cancer screening. This co-design process will collaboratively explore barriers and solutions to poor bowel cancer awareness, poor information seeking behaviour and poor engagement with routine screening exercise. It is expected that the co-design process will lead to the development of educational resources or services bespoke to the rural community, thereby encouraging mass adoption and improvement in health outcomes. Funded by: Cancer Council of Tasmania - Grant-Small ($25,000); University of Tasmania.
  • GRANT
    Determining dose response variations in human absorption and metabolism of anthocyanins from Tasmanian sweet cherries: a pilot cross-over study
    1 Apr 2018 - 31 Dec 2018
    People funded by this grant:
    • Kent K,
    • Swarts N,
    • Sharman M,
    • Charlton K
    Project Total: $18,551; A pilot-crossover study aims to determine and compare the dose-response variation of anthocyanins and phenolic metabolites in urine and faecal matter in humans over 24h after consumption of anthocyanin-rich sweet cherries. Funded by: University of Tasmania - Grant-BH Research Theme; University of Tasmania ($18,551).
  • GRANT
    A RANDOMISED CLINICAL TRIAL OF PHYSICAL ACTIVITY TO DELAY THE PROGRESSION OF CEREBROVASCULAR PATHOLOGY
    15 Sep 2014 - 30 Dec 2015
    People funded by this grant:
    • Lautenschlager N,
    • Desmond P,
    • Cox K,
    • Ames D,
    • Szoeke C
    Project Total: $632,153; The aim of this randomised clinical trial is to establish whether a 24 months physical activity (PA) program for older adults with memory problems can delay the progression of damage to the blood vessel system in the brain, measured on an MRI scan. It also will investigate whether cognition, mood, quality of life, functional level, fitness and biological markers will improve with the intervention. If successful this PA program could become part of clinical care for adults at risk of dementia. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project; National Ageing Research Institute; University of Tasmania.
  • GRANT
    The role of a presenilin 2 truncation (PS2V) in Alzheimer's Disease
    5 Aug 2014 - 31 Jan 2017
    People funded by this grant:
    • Sharman M
    Project Total: $543,036; The Presenilin and APP proteins are centrally important in inherited, early onset Alzheimer's disease. We have discovered that a shortened form of Presenilin protein, 'PS2V', appears to increase specifically the rate at which the APP protein is cleaved to produce the 'Amyloid beta' protein fragment that is found in Alzheimer's disease brains. This occurs when brain cells are under oxidative stress. Understanding this process will facilitate development of appropriate therapeutic strategies for the disease. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project; University of Tasmania.